Harshal J Profile

Asia-Pacific Livestock Diagnostics Market by Product (Consumables {Swine Fever, Influenza}, System, Software), Technology (Immunodiagnostics {ELISA, LFA}, PCR), Animal Type (Swine, Bovine, Poultry), End User (POC, Veterinary Hospital) – Forecast to 2030

The Asia-Pacific Livestock Diagnostics Market is expected to record a CAGR of 10% from 2023 to 2030, reaching $501.8 million by 2030. Livestock serves as a major sector as a financial resource for the agriculture-based economy of Asia-Pacific. The countries in Asia-Pacific have a major focus on the production, consumption, and export of food-derived products. In order to ensure the highest quality of products derived from animals, superior animal health is essential. Diagnostics is crucial to keep animals healthy by enabling early disease diagnosis and stopping the disease spread amongst animals. Technologies such as immunodiagnostics and molecular Diagnostics are used to diagnose diseases such as influenza, swine fever, brucellosis, and new castle diseases, among others.

The growth of this market is driven by the growing demand for animal-derived food products, the increasing prevalence of transboundary and zoonotic diseases, and favorable government initiatives. Additionally, increasing awareness regarding animal health amongst farmers is expected to create growth opportunities for the stakeholders in this market. However, the dearth of veterinary practitioners for livestock animals restrains the growth of this market. Moreover, the lack of well-developed animal health infrastructure in the region poses a challenge for the market.

Asia-Pacific Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs) – Forecast to 2030

The Asia-Pacific Continuous Bioprocessing Market is expected to grow at a CAGR of 28.9% from 2023 to 2030 to reach $181.1 million by 2030. Continuous manufacturing is an emerging trend spanning various industries. From automotive to paper, businesses are embracing continuous manufacturing to enhance efficiency and bolster profits. The shift from batch to continuous manufacturing is gaining traction in the biopharmaceuticals sector due to the surge in demand for intricate therapies and heightened market competition. Continuous bioprocessing is increasingly being adopted due to its agility, flexibility, efficiency, and robustness. This approach streamlines processes by minimizing steps, utilizing compact facilities and equipment, and enhancing product quality to facilitate real-time release.

The growth of the continuous bioprocessing market in Asia-Pacific is attributed to the gradual adoption of continuous manufacturing, rising manufacturing and research-related outsourcing of biopharmaceuticals, expansions in CDMOs, and initiatives supporting the adoption of biopharmaceuticals. Furthermore, the shift towards bioprocessing 4.0 and the rising adoption of personalized medicines are expected to provide significant market growth opportunities.

However, the limitations of continuous bioprocessing may restrain the growth of this market. Additionally, manufacturers’ hesitation to shift from batch manufacturing to continuous manufacturing poses challenges to the market players.

Asia-Pacific Air Conditioners Market by Type (Split, Centralized/Ducted, Others), Tonnage (Up to 2 Tons, 2 Tons to 5 Tons, Others), Technology (Inverter, Non-inverter), Rating (5 Star, 4 Star, Others), End User (Residential, Others), and Geography – Forecast 2030

The Asia-Pacific Air Conditioners Market is projected to reach $122.06 billion by 2030, at a CAGR of 6.4% during the forecast period of 2023–2030. The growth of the Asia-Pacific air conditioners market is attributed to the rising temperatures & humidity levels in the region, consumers’ growing inclination toward convenience & comfort, and the rising demand for energy-efficient air conditioners. However, the high costs of air conditioners restrain the growth of this market.

The rising adoption of air conditioners with inverter & air purification technologies and technological advancements in HVAC systems are creating growth opportunities for the players operating in this market. However, the high energy consumption associated with air conditioners is a challenge for market growth. Additionally, connected air conditioners and solar photovoltaic (PV) & solar thermal-assisted air conditioning systems are major trends in this market.

Nematicides Market by Type (Chemical {Organophosphate, Carbamate, Fumigant}, Biological {Microbial [Bacillus Species]}, Biochemical), Form, Nematode Type (Root-knot, Cyst Nematodes), Mode of Application (Seed Treatment), Crop Type – Global Forecast to 2030

The Nematicides Market is projected to reach $3.58 billion by 2030, at a CAGR of 8.9% during the forecast period of 2023–2030. In terms of volume, the nematicides market is projected to reach 182,932.2 tons by 2030, at a CAGR of 8.5% during the forecast period of 2023–2030. The growth of this market is driven by the rising demand for organic foods, growing environmental concerns, and market players’ focus on product launches and acquisitions. However, the lack of awareness and low adoption of bionematicides and stringent and non-standardized regulations restrain the growth of this market. Moreover, emerging markets in Asia-Pacific and Latin America and the growing adoption of biological seed treatments are expected to generate growth opportunities for the players operating in this market. However, the limited availability of bionematicides is a challenge for market stakeholders. Additionally, the growing utilization of sustainable agricultural inputs is a major trend in the nematicides market.

Middle East & Africa Edible Insects Market by Product (Whole Insect, Insect Powder, Insect Meal), Insect Type (Crickets, Black Soldier Fly, Mealworms, Ants), Application (Animal Feed, Protein Bar & Shakes, Bakery, Confectionery), and Geography – Forecast to 2030

The Middle East & Africa Edible Insects Market is expected to reach $282.9 million by 2030, at a CAGR of 22.4% from 2023 to 2030. The growth of this market is attributed to several factors, including the high nutritional value of insects, the increasing greenhouse gas emissions from the livestock and poultry industries, the environmental benefits associated with consuming edible insects, the increasing utilization of insects in animal feeds by feed processors and farmers, and the low risk of transmitting zoonotic diseases through the consumption of edible insects. Moreover, the rising consumer demand for more sustainable food and feed products, along with government support for insect farming, offers significant growth opportunities for market players.

However, the absence of a standardized regulatory framework, psychological and ethical barriers to consuming insects as food, and the potential risk of allergies associated with insect consumption restrain the market’s growth. Additionally, the lack of awareness regarding the benefits of insect consumption remains a major challenge for the growth of this market.

Farm Management Software Market by Offerings (Software, Services), Application (Precision Farming, Aquaculture, Livestock Monitoring, Smart Greenhouse), Farm Size, End User, and Geography – Global Forecast to 2030

The Farm Management Software Market to reach $10.5 billion by 2030, at a CAGR of 25.4% from 2023 to 2030. The growth of this market is attributed to the increasing adoption of connectivity in agriculture, increasing adoption of farm management for improving yields, environmental factors such as climate change and water shortage driving the adoption of farm management software, and government initiatives to drive the adoption of farm management software driving market growth. In addition, the adoption of new business models by agritech companies, making farm management software affordable for farmers, and the emerging need for AI in agriculture are expected to offer significant opportunities for the growth of this market.

However, the lack of access to financial solutions for farmers hampers the growth of this market. In addition, the fragmented and unorganized agriculture ecosystem in developing countries is a major challenge to the growth of this market.

Single-use Bioreactors Market by Product [Systems, Media Bags (2D, 3D), Filtration Assemblies], Type [Stirred-tank, Wave-induced], Cell [Mammalian, Bacterial, Yeast], Application [Commercial (Mab, Vaccine), Research], End User – Global Forecast to 2030

The Single-use Bioreactors Market is projected to reach $10.3 billion by 2030, at a CAGR of 15.8% from 2023 to 2030. Single-use bioreactors, also called disposable bioreactors, are made of disposable bags instead of a culture vessel. These bioreactors eliminate the need for expensive and bulky clean-in-place (CIP) or steam-in-place (SIP) systems and offer flexibility and a low risk of contamination, contributing to their adoption by pharma & biotech companies. These companies are focusing on organic & inorganic strategies like expanding manufacturing capacity or acquisitions to increase their bioproduction, increasing the adoption of biopharma equipment, including bioreactors.

For instance, in December 2022, Thermo Fisher Scientific Inc. (U.S.) expanded its presence in Hangzhou, China, to support customers' manufacturing needs, enabling them to serve more patients worldwide. This site offers integrated clinical and commercial drug substance and drug product capabilities, including process development, cell line development, biologics drug substance manufacturing and sterile fill-finish. This includes the use of packaging and labeling capabilities. Advanced technologies in the facility include Thermo Fisher 2,000-liter HyPerforma Single-Use Bioreactors and associated Single-Use equipment and, in the future, bioreactor capacity up to 5,000 liters through Thermo Scientific DynaDrive technology.

In March 2021, Pall Corporation (U.S.), a subsidiary of Danaher Corporation (U.S.), acquired Pall-Austar Lifesciences Limited (Hong Kong) (a joint Venture between Pall and Austar Group). This acquisition is intended to expand the single-use technology manufacturing capabilities of the company in China for products supporting the scale-up of COVID-19 vaccines.

The rapid adoption of disposable technology in the pharmaceutical and biotechnology industry, growing demand for biopharmaceuticals, and capacity expansion of biopharmaceutical plants are some of the major factors driving the growth of the single-use bioreactors market.

Network Security Firewall Market by Component (Solutions, Services), Type (Unified Threat Management, Next-generation Firewall), Deployment Mode, Organization Size, and Sector (BFSI, Retail, and Other Sectors) and Geography – Global Forecast to 2030

The Network Security Firewall Market to reach $16.2 billion by 2030 at a CAGR of 19.7% during 2023–2030. The growth of the network security firewall market is driven by the rising government regulations encouraging the demand for network security firewalls, the growing significance of network security firewall solutions in the BFSI sector, the increasing demand for network security and privacy, and the advancement of digital transformation in the telecommunication industry. However, the lack of preventive firewall maintenance restrains the growth of the network security firewall market.

Further, the growing need for network security firewall solutions among SMEs and increasing adoption of network function virtualization is expected to create market growth opportunities. Also, misconceptions & lack of knowledge regarding network security firewall solutions are challenging for the players operating in this market.

Antiviral & Antimicrobial Coatings Market by Type (Antimicrobial, Antiviral), Material (Copper, Silver, Aluminum), Form (Powder, Aerosol), Application (Healthcare, Building & Construction, Automotive, Packaging), and Geography – Forecast to 2028

The Antiviral & Antimicrobial Coatings Market is expected to grow at a CAGR of 11.7% from 2021 to 2028 to reach $8.53 billion by 2028. Antiviral & antimicrobial coatings are used to restrict the growth of viruses and other microorganisms. These coatings provide long-lasting protection against microorganisms and help maintain permanent hygiene. They have wide applications in healthcare, building & construction, food & beverage, packaging, air & water treatment, automotive, protective clothing, and other industries like oil & gas, electronics, and aeronautics & defense.

The growth of this market is mainly attributed to the increasing incidence of healthcare-associated infections, the rising number of food product recalls due to microbial contamination, and government initiatives & funding for the development of antimicrobial coatings. Favorable development in the emerging economies is expected to offer significant growth opportunities for players in this market. However, stringent government regulation on the emission of volatile organic compounds (VOCs) is expected to restrain the growth of this market to a certain extent. Additionally, the growing antimicrobial resistance among micro-organisms is expected to pose challenges to market growth.

U.S. Water and Wastewater Treatment Technologies Market by Treatment Technologies Type (Membrane Separation & Filtration, Sludge Management Technology, Activated Sludge, Clarification) and Application – Forecasts to 2029

The U.S. Water and Wastewater Treatment Technologies Market is expected to reach a value of $24.63 billion by 2029, at a CAGR of 5% during the forecast period 2022–2029. The growth of the U.S. water and wastewater treatment technologies market is attributed to stringent regulations on the safe and appropriate use of onsite wastewater treatment systems (OWTS), improvements in wastewater treatment technology, and the increasing prevalence of waterborne diseases.

Furthermore, the growing demand for energy-efficient and advanced water treatment technologies is expected to provide significant growth opportunities for the vendors operating in the U.S. water and wastewater treatment technologies market. However, the high installation, maintenance, and operational costs are expected to hinder the growth of this market to a notable extent. In addition, the aging and deterioration of existing water infrastructure are the challenges for the growth of the U.S. water and wastewater treatment technologies market.